Figure 2.
Fc-galactosylation does not increase CD20 binding of rituximab-derived IgG isotypes. Target antigen recognition by galactosylated and degalactosylated human IgG1–4 isotypes specific for CD20 analyzed by flow cytometry via titration on CD20+ Raji cells. MFI, median fluorescence intensity; IgG, immunoglobulin gamma.